Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7727682rdf:typepubmed:Citationlld:pubmed
pubmed-article:7727682lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:7727682lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:7727682lifeskim:mentionsumls-concept:C1148670lld:lifeskim
pubmed-article:7727682lifeskim:mentionsumls-concept:C0178756lld:lifeskim
pubmed-article:7727682lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:7727682pubmed:issue4lld:pubmed
pubmed-article:7727682pubmed:dateCreated1995-6-1lld:pubmed
pubmed-article:7727682pubmed:abstractTextThe preparation of 5-substituted 1-aryl-4,5-dihydro-1H-pyrazolo[4,3- c][1,8] naphthyridines by reaction of 5-substituted 3-hydroxymethylene-2,3-dihydro-1,8-naphthyridin-4(1H)-ones with various phenylhydrazines is described. The benzodiazepine binding activity of these compounds was evaluated in vitro. Only the 5-methyl substituted derivatives showed affinity for the benzodiazepine receptor, with K1 values ranging from 2.9 to 0.195 microM for the para-phenyl substituted compounds. A hypothesis of interaction of these ligands with the receptor site is reported.lld:pubmed
pubmed-article:7727682pubmed:languageenglld:pubmed
pubmed-article:7727682pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7727682pubmed:citationSubsetIMlld:pubmed
pubmed-article:7727682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7727682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7727682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7727682pubmed:statusMEDLINElld:pubmed
pubmed-article:7727682pubmed:monthJunlld:pubmed
pubmed-article:7727682pubmed:issn1055-9612lld:pubmed
pubmed-article:7727682pubmed:authorpubmed-author:LucacchiniAAlld:pubmed
pubmed-article:7727682pubmed:authorpubmed-author:MartinsUUlld:pubmed
pubmed-article:7727682pubmed:authorpubmed-author:Da SettimoAAlld:pubmed
pubmed-article:7727682pubmed:authorpubmed-author:PrimofioreGGlld:pubmed
pubmed-article:7727682pubmed:authorpubmed-author:BariliP LPLlld:pubmed
pubmed-article:7727682pubmed:authorpubmed-author:Da SettimoFFlld:pubmed
pubmed-article:7727682pubmed:authorpubmed-author:SenatoreGGlld:pubmed
pubmed-article:7727682pubmed:authorpubmed-author:SimoriniFFlld:pubmed
pubmed-article:7727682pubmed:issnTypePrintlld:pubmed
pubmed-article:7727682pubmed:volume11lld:pubmed
pubmed-article:7727682pubmed:ownerNLMlld:pubmed
pubmed-article:7727682pubmed:authorsCompleteYlld:pubmed
pubmed-article:7727682pubmed:pagination307-28lld:pubmed
pubmed-article:7727682pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7727682pubmed:meshHeadingpubmed-meshheading:7727682-...lld:pubmed
pubmed-article:7727682pubmed:meshHeadingpubmed-meshheading:7727682-...lld:pubmed
pubmed-article:7727682pubmed:meshHeadingpubmed-meshheading:7727682-...lld:pubmed
pubmed-article:7727682pubmed:meshHeadingpubmed-meshheading:7727682-...lld:pubmed
pubmed-article:7727682pubmed:meshHeadingpubmed-meshheading:7727682-...lld:pubmed
pubmed-article:7727682pubmed:meshHeadingpubmed-meshheading:7727682-...lld:pubmed
pubmed-article:7727682pubmed:year1994lld:pubmed
pubmed-article:7727682pubmed:articleTitleSynthesis and benzodiazepine receptor activity of some 4,5-dihydro-1H-pyrazolo[4,3-c][1,8]naphthyridine derivatives.lld:pubmed
pubmed-article:7727682pubmed:affiliationIstituto Chimica Farmaceutica e Tossicologica, Università di Pisa, Italy.lld:pubmed
pubmed-article:7727682pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7727682pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7727682lld:pubmed